Alessandra Ferrajoli

11PUBLICATIONS
104CO-AUTHORS
Respiratory diseasesCancer therapy (excl. chemotherapy and radiation therapy)PharmacogenomicsCancer geneticsHaematological tumours
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (11)

|Jul 15, 2026
Adjunct Hyperbaric Oxygen Therapy for Refractory Infections in Patients with Hematologic Malignancies: A Single-Center Retrospective Study.

|Feb 12, 2026
Ibrutinib with Venetoclax in Patients with Relapsed/Refractory Chronic Lymphocytic Leukemia: A Phase II Study.

Mahesh Swaminathan, Alessandra Ferrajoli, Philip A Thompson

|Oct 28, 2025
Pharmacological profiling in CLL patients during pirtobrutinib therapy and disease progression.

Shady I Tantawy, Burcu Aslan, Ganiraju Manyam

|Jul 12, 2025
Best Supportive Care for Patients with Chronic Lymphocytic Leukemia: Relevance of Cancer Screening and Immunizations.

Vanthana Bharathi, Alessandra Ferrajoli

|Feb 19, 2025
The mutational landscape and functional effects of noncoding ultraconserved elements in human cancers.

Recep Bayraktar, Yitao Tang, Mihnea P Dragomir

|Oct 23, 2024
Deuterated water labeling in ibrutinib-treated patients with CLL: leukemia cell kinetics correlate with IGHV, ZAP-70, and MRD.

Ekaterina Kim, Shih-Shih Chen, Mariela Sivina

Pageof 2

Frequent Collaborators

3 joint publications

William G Wierda

3 joint publications

Nitin Jain

2 joint publications

Naveen Pemmaraju

2 joint publications

Hagop M Kantarjian